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Abstract  
Carvacrol (CARV) presents valuable biological properties such as anti-inflammatory and antioxidant 
activities. However, pharmacological uses of CARV are largely limited due to disadvantages related 
to solubility, bioavailability, preparation and storage processes. The complexation of monoterpenes 
with β-cyclodextrin (β-CD) increases their stability, solubility and oral bioavailability. Here, the 
protective effect of oral treatment with CARV/β-CD complex (25 μg/kg/day) against dopaminergic 
(DA) denervation induced by unilateral intranigral injection of 6-hydroxydopamine (6-OHDA - 10 μg 
per rat) was analyzed, in order to evaluate a putative application in the development of 
neuroprotective therapies for Parkinson's disease (PD). Pretreatment with CARV/β-CD for 15 days 
prevented the loss of DA neurons induced by 6-OHDA in adult Wistar rats. This effect may occur 
through CARV anti-inflammatory and antioxidant properties, as the pretreatment with CARV/β-CD 
inhibited the release of IL-1β and TNF-α; besides, CARV prevented the increase of mitochondrial 
superoxide production induced by 6-OHDA in cultured SH-SY5Y cells. Importantly, hepatotoxicity or 
alterations in blood cell profile were not observed with oral administration of CARV/β-CD. 
Therefore, this study showed a potential pharmacological application of CARV/β-CD in PD using a 
non-invasive route of drug delivery, i.e., oral administration. 
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